Gene · 701
Papers3,969
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 3,969
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| NamiRNA-mediated high expression of KNSTRN correlates with poor prognosis and immune infiltration in hepatocellular carcinoma. | Contemp Oncol (Pozn) | 2023 | 38239867 | PubTator, text mining | PubMed |
| BRCA Mutations and Fertility Preservation. | Int J Mol Sci | 2023 | 38203374 | PubTator, text mining | PubMed |
| Genetic Alterations of NF-κB and Its Regulators: A Rich Platform to Advance Colorectal Cancer Diagnosis and Treatment. | Int J Mol Sci | 2023 | 38203325 | PubTator, text mining | PubMed |
| Natural Anticancer Peptides from Marine Animal Species: Evidence from In Vitro Cell Model Systems. | Cancers (Basel) | 2023 | 38201464 | PubTator, text mining | PubMed |
| mDia formins form hetero-oligomers and cooperatively maintain murine hematopoiesis. | PLoS Genet | 2023 | 38157491 | PubTator, text mining | PubMed |
| Comprehensive analysis of the prognostic implication and immune infiltration of CISD2 in diffuse large B-cell lymphoma. | Front Immunol | 2023 | 38155967 | PubTator, text mining | PubMed |
| circMORC3-encoded novel protein negatively regulates antiviral immunity through synergizing with host gene MORC3. | PLoS Pathog | 2023 | 38150467 | PubTator, text mining | PubMed |
| Anti-tumor target screening of sea cucumber saponin Frondoside A: a bioinformatics and molecular docking analysis. | Front Oncol | 2023 | 38144520 | PubTator, text mining | PubMed |
| Chemically induced revitalization of damaged hepatocytes for regenerative liver repair. | iScience | 2023 | 38144457 | PubTator, text mining | PubMed |
| Transcriptomic correlates of cell cycle checkpoints with distinct prognosis, molecular characteristics, immunological regulation, and therapeutic response in colorectal adenocarcinoma. | Front Immunol | 2023 | 38143740 | PubTator, text mining | PubMed |
| Systematic analysis of Mendelian disease-associated gene variants reveals new classes of cancer-predisposing genes. | Genome Med | 2023 | 38143269 | PubTator, text mining | PubMed |
| Analytic Validation of Optical Genome Mapping in Hematological Malignancies. | Biomedicines | 2023 | 38137484 | PubTator, text mining | PubMed |
| C-Type Natriuretic Peptide Pre-Treatment Improves Maturation Rate of Goat Oocytes by Maintaining Transzonal Projections, Spindle Morphology, and Mitochondrial Function. | Animals (Basel) | 2023 | 38136917 | PubTator, text mining | PubMed |
| Age-Associated Changes of Sirtuin 2 Expression in CNS and the Periphery. | Biology (Basel) | 2023 | 38132302 | PubTator, text mining | PubMed |
| Systematic review and integrated analysis of prognostic gene signatures for prostate cancer patients. | Discov Oncol | 2023 | 38112859 | PubTator, text mining | PubMed |
| Genetic and epigenetic features of bilateral Wilms tumor predisposition in patients from the Children's Oncology Group AREN18B5-Q. | Nat Commun | 2023 | 38110397 | PubTator, text mining | PubMed |
| Crowdsourcing temporal transcriptomic coronavirus host infection data: Resources, guide, and novel insights. | Biol Methods Protoc | 2023 | 38107402 | PubTator, text mining | PubMed |
| Carmofur prevents cell cycle progression by reducing E2F8 transcription in temozolomide-resistant glioblastoma cells. | Cell Death Discov | 2023 | 38086808 | PubTator, text mining | PubMed |
| Analysis of gene expression profile for identification of novel gene signatures during dengue infection. | Infect Med (Beijing) | 2023 | 38076406 | PubTator, text mining | PubMed |
| Comprehensive Profiling and Therapeutic Insights into Differentially Expressed Genes in Hepatocellular Carcinoma. | Cancers (Basel) | 2023 | 38067357 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/701/papers?page=13